A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis

OBJECTIVES: 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors (statins) are standard treatment for hyperlipidaemia. In addition to lipid-lowering abilities, statins exhibit multiple anti-inflammatory effects. The objectives of this study were to determine whether treatment of pat...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Rheumatology (Oxford)
المؤلفون الرئيسيون: Aranow, Cynthia, Cush, John, Bolster, Marcy B, Striebich, Christopher C, Dall’era, Maria, Mackay, Meggan, Olech, Ewa, Frech, Tracy, Box, Jane, Keating, Richard, Wasko, Mary Chester, St Clair, William, Kivitz, Alan, Huang, Weiquang, Ricketts, PetaGay, Welch, Beverly, Callahan, Sherrie, Spychala, Meagan, Boyle, Karen, York, Kate, Keyes-Elstein, Lynette, Goldmuntz, Ellen, Diamond, Betty, Davidson, Anne
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2020
الموضوعات:
Clinical Science
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310095/
https://ncbi.nlm.nih.gov/pubmed/31628482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez471
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة